UnitedHealth Group (NYSE:UNH) Updates FY 2019 Earnings Guidance
UnitedHealth Group (NYSE:UNH) issued an update on its FY 2019 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $14.15-14.25 for the period.
Shares of NYSE:UNH opened at $220.59 on Tuesday. The stock has a market capitalization of $210.45 billion, a PE ratio of 17.13, a P/E/G ratio of 1.18 and a beta of 0.60. UnitedHealth Group has a 1 year low of $208.07 and a 1 year high of $287.94. The firm has a fifty day moving average price of $226.54 and a 200 day moving average price of $239.74. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.62.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $3.46 by $0.14. The firm had revenue of $60.60 billion during the quarter, compared to analysts’ expectations of $60.59 billion. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. UnitedHealth Group’s revenue for the quarter was up 8.0% on a year-over-year basis. During the same period in the prior year, the company posted $3.14 earnings per share. On average, sell-side analysts forecast that UnitedHealth Group will post 14.83 earnings per share for the current fiscal year.
UNH has been the subject of a number of recent research reports. Raymond James upped their price objective on shares of UnitedHealth Group from $265.00 to $300.00 and gave the stock a buy rating in a report on Friday, July 19th. Morgan Stanley decreased their price objective on shares of UnitedHealth Group from $298.00 to $294.00 and set an overweight rating for the company in a report on Thursday, September 26th. Barclays set a $260.00 price objective on shares of UnitedHealth Group and gave the stock a buy rating in a report on Tuesday, October 8th. Oppenheimer set a $312.00 price objective on shares of UnitedHealth Group and gave the stock a buy rating in a report on Friday, July 19th. Finally, ValuEngine upgraded shares of UnitedHealth Group from a sell rating to a hold rating in a report on Wednesday, October 2nd. Five analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. The stock currently has a consensus rating of Buy and an average price target of $283.22.
In related news, Director Richard T. Burke sold 2,500 shares of the stock in a transaction dated Thursday, September 19th. The shares were sold at an average price of $233.40, for a total value of $583,500.00. Following the completion of the sale, the director now owns 187,979 shares in the company, valued at $43,874,298.60. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Richard T. Burke sold 2,000 shares of the stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $231.50, for a total transaction of $463,000.00. Following the completion of the sale, the director now owns 187,979 shares of the company’s stock, valued at approximately $43,517,138.50. The disclosure for this sale can be found here. In the last quarter, insiders sold 24,000 shares of company stock valued at $5,924,120. 0.82% of the stock is owned by corporate insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: What is Elliott Wave theory?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.